Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Plos One|February 4, 2021
Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clustersKeita Fukuyama, Masataka Asagiri, Masahiro Sugimoto, et al.Hepatology (Baltimore, Md.)|August 8, 2015
Hepatic stellate cells relay inflammation signaling from sinusoids to parenchyma in mouse models of immune-mediated hepatitisTomoko Fujita, Kitipong Soontrapa, Yoshiya Ito, et al.Molecular Therapy. Methods & Clinical Development|June 2, 2015
Efficient inhibition of tumor angiogenesis and growth by a synthetic peptide blocking S100A4-methionine aminopeptidase 2 interactionTakahiro Ochiya, Keizo Takenaga, Masataka Asagiri, et al.Plos One|October 8, 2010
Axonal-transport-mediated gene transduction in the interior of rat boneToshitaka Okabayashi, Kuniaki Nakanishi, Toyokazu Tsuchihara, et al.American Journal of Physiology. Cell Physiology|November 13, 2023
Caveolin-1 forms a complex with P2X7 receptor and tunes P2X7-mediated ATP signaling in mouse bone marrow-derived macrophagesYuuki Sawai, Yoshiaki Suzuki, Masataka Asagiri, et al.Biochemical and Biophysical Research Communications|August 8, 2022
Dantrolene, a stabilizer of the ryanodine receptor, prevents collagen-induced arthritisTakashi Nawata, Hiroki Sakai, Takeshi Honda, et al.Biochemical and Biophysical Research Communications|March 30, 2024
Renoprotective effects of laxative linaclotide: Inhibition of acute kidney injury and fibrosis in a rat model of renal ischemia-reperfusionYukihiro Hitaka, Naohito Isoyama, Shunya Tsuji, et al.International Archives of Allergy and Immunology|March 21, 2015
Inhibition of MMP-2-Mediated Mast Cell Invasion by NF-κB Inhibitor DHMEQ in Mast CellsNaruto Noma, Masataka Asagiri, Masatoshi Takeiri, et al.Nature|April 1, 2005
IRF-7 is the master regulator of type-I interferon-dependent immune responsesKenya Honda, Hideyuki Yanai, Hideo Negishi, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 15, 2005
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1Hiroshi Takatsuna, Masataka Asagiri, Takeshi Kubota, et al.Pageof 6